These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1968558)

  • 1. Ineffectiveness of AL721 in HIV disease.
    Peters BS; Bennett JM; Jeffries DJ; Knox K; Kocsis A; Pinching AJ
    Lancet; 1990 Mar; 335(8688):545-6. PubMed ID: 1968558
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression of HIV antigenaemia by AL721.
    Shinitzky M; Skornick Y
    Lancet; 1990 May; 335(8700):1281-2. PubMed ID: 1971348
    [No Abstract]   [Full Text] [Related]  

  • 3. NIH-sponsored clinical trials begin for antiviral drug AL721.
    Bennett J
    Am J Nurs; 1988 Apr; 88(4):432. PubMed ID: 3279780
    [No Abstract]   [Full Text] [Related]  

  • 4. Controversial AIDS drug for US market.
    Barinaga M
    Nature; 1988 Apr; 332(6164):475. PubMed ID: 3357506
    [No Abstract]   [Full Text] [Related]  

  • 5. [Epidemiological news on infectious diseases].
    Vella S; Rocchi G
    Medicina (Firenze); 1988; 8(2):233-4. PubMed ID: 2852294
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of AIDS with AL-721.
    Klajman A
    Isr J Med Sci; 1990 Jan; 26(1):2-4. PubMed ID: 2179156
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduction of circulating HIV antigens in seropositive patients after treatment with AL-721.
    Yust I; Vardinon N; Skornick Y; Zakuth V; Hasner A; Shinitzky M
    Isr J Med Sci; 1990 Jan; 26(1):20-6. PubMed ID: 2179157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open study of AL-721 treatment of HIV-infected subjects with generalized lymphadenopathy syndrome: an eight week open trial and follow-up.
    Grieco MH; Lange M; Buimovici-Klein E; Reddy MM; Englard A; McKinley GF; Ong K; Metroka C
    Antiviral Res; 1988 Apr; 9(3):177-90. PubMed ID: 2456739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open-label, dose-ranging trial of AL 721 in patients with persistent generalized lymphadenopathy and AIDS-related complex.
    Mildvan D; Buzas J; Armstrong D; Antoniskis D; Sacks HS; Rhame FS; Mosbach EW; Pettinelli C
    J Acquir Immune Defic Syndr (1988); 1991; 4(10):945-51. PubMed ID: 1890604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AL721, a novel membrane fluidizer.
    Antonian L; Shinitzky M; Samuel D; Lippa AS
    Neurosci Biobehav Rev; 1987; 11(4):399-413. PubMed ID: 3325866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atopic dermatitis provoked by AL721 in a patient with acquired immunodeficiency syndrome.
    Wolf R; Ophir J; Yust I
    Ann Allergy; 1991 May; 66(5):421-3. PubMed ID: 2035906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trial.
    Chaisson RE; Leuther MD; Allain JP; Nusinoff-Lehrman S; Boone GS; Feigal D; Volberding P
    Arch Intern Med; 1988 Oct; 148(10):2151-3. PubMed ID: 3263098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Will new treatment cause remission in AIDS patients?
    Moran EJ
    Hospitals; 1990 Feb; 64(3):72. PubMed ID: 2298431
    [No Abstract]   [Full Text] [Related]  

  • 14. 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trial.
    Lambert JS; Seidlin M; Reichman RC; Plank CS; Laverty M; Morse GD; Knupp C; McLaren C; Pettinelli C; Valentine FT
    N Engl J Med; 1990 May; 322(19):1333-40. PubMed ID: 2139173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Once-daily administration of 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Results of a Phase I trial.
    Cooley TP; Kunches LM; Saunders CA; Ritter JK; Perkins CJ; McLaren C; McCaffrey RP; Liebman HA
    N Engl J Med; 1990 May; 322(19):1340-5. PubMed ID: 2139174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of azidothymidine (AZT) on P24 antigen levels in patients with AIDS-related complex and AIDS.
    Reddy MM; McKinley G; Englard A; Grieco MH
    J Clin Lab Anal; 1989; 3(4):199-201. PubMed ID: 2503599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Zidovudine (AZT). Current state of the development].
    Kouzan S; Nebout T
    Ann Med Interne (Paris); 1991; 142(6):444-55. PubMed ID: 1772186
    [No Abstract]   [Full Text] [Related]  

  • 18. New ddI information.
    Randall PS
    Minn Med; 1990 Dec; 73(12):12. PubMed ID: 2127299
    [No Abstract]   [Full Text] [Related]  

  • 19. [HIV-correlated antigens and antibodies in patients treated with zidovudine].
    Garavelli PL; Dallavalle FM
    Minerva Med; 1990; 81(7-8 Suppl):93-4. PubMed ID: 2216047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Trial of danazol and zidovudine combination in HIV infection. Increased risk of cutaneous allergy].
    Lang JM; Dossou-Gbete V; De Mautort E; Zorn A; Steckmeyer M
    Presse Med; 1989 Sep; 18(30):1480. PubMed ID: 2534177
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.